Feasibility and Preliminary Efficacy of Behavioral Activation for Treatment of Depression in Autistic Adolescents

Saved in:
Bibliographic Details
Title: Feasibility and Preliminary Efficacy of Behavioral Activation for Treatment of Depression in Autistic Adolescents
Language: English
Authors: Michelle Menezes (ORCID 0000-0003-0155-8367), Christina Burroughs, Jessica Pappagianopoulos, Eleonora Sadikova, Emily Fuhrmann, Genevieve Bohac, Robert Cross, Lauren Witte, Gabrielle Brinkmann, Rachel Lemley, Denis G. Sukhodolsky (ORCID 0000-0002-5401-792X), Micah O. Mazurek (ORCID 0000-0001-7715-6538)
Source: Autism: The International Journal of Research and Practice. 2024 28(12):3021-3032.
Availability: SAGE Publications. 2455 Teller Road, Thousand Oaks, CA 91320. Tel: 800-818-7243; Tel: 805-499-9774; Fax: 800-583-2665; e-mail: journals@sagepub.com; Web site: https://sagepub.com
Peer Reviewed: Y
Page Count: 12
Publication Date: 2024
Document Type: Journal Articles
Reports - Research
Descriptors: Behavior Modification, Outcomes of Treatment, Depression (Psychology), Autism Spectrum Disorders, Adolescents, Intervention, Program Evaluation, Mental Health, Symptoms (Individual Disorders), Anxiety, Interpersonal Competence, Children, Child Behavior
Assessment and Survey Identifiers: Childrens Depression Inventory, Wechsler Abbreviated Scale of Intelligence, Social Skills Improvement System Rating Scales
DOI: 10.1177/13623613241252470
ISSN: 1362-3613
1461-7005
Abstract: Depression is common among autistic youth and is associated with worse quality of life in this group. Despite significant need for high-quality efficacious treatments, there has been very limited research on interventions for depression in autistic youth. This single-arm pilot study examined the feasibility and preliminary efficacy of a novel, behavior-based approach for treatment of depression symptoms in autistic adolescents without intellectual disability (i.e. Behavioral Activation for Autistic Adolescents, BA-A). BA-A is an individually delivered manualized 12-session treatment that utilizes established BA strategies and incorporates common mental health treatment adaptations for autistic young people. Of the 18 youth (11-16 years old) who enrolled, 15 completed all 12 treatment sessions, as well as pre-treatment, post-treatment, and follow-up assessment visits. Clinician treatment fidelity was quite high. Paired sample t-tests found that depression symptoms decreased pre- to post-BA-A according to multiple informants (i.e. self, caregiver, and independent evaluator), and treatment gains were maintained at 1-month follow-up. Paired sample t-tests also found that caregiver-reported anxiety symptoms and social skills improved pre-treatment to post-treatment. The results, although preliminary, indicate that BA-A may improve depression symptoms in autistic youth without intellectual disability. Furthermore, these promising findings suggest that a randomized controlled trial of BA-A is warranted.
Abstractor: As Provided
Entry Date: 2024
Accession Number: EJ1449942
Database: ERIC
Full text is not displayed to guests.
Description
Abstract:Depression is common among autistic youth and is associated with worse quality of life in this group. Despite significant need for high-quality efficacious treatments, there has been very limited research on interventions for depression in autistic youth. This single-arm pilot study examined the feasibility and preliminary efficacy of a novel, behavior-based approach for treatment of depression symptoms in autistic adolescents without intellectual disability (i.e. Behavioral Activation for Autistic Adolescents, BA-A). BA-A is an individually delivered manualized 12-session treatment that utilizes established BA strategies and incorporates common mental health treatment adaptations for autistic young people. Of the 18 youth (11-16 years old) who enrolled, 15 completed all 12 treatment sessions, as well as pre-treatment, post-treatment, and follow-up assessment visits. Clinician treatment fidelity was quite high. Paired sample t-tests found that depression symptoms decreased pre- to post-BA-A according to multiple informants (i.e. self, caregiver, and independent evaluator), and treatment gains were maintained at 1-month follow-up. Paired sample t-tests also found that caregiver-reported anxiety symptoms and social skills improved pre-treatment to post-treatment. The results, although preliminary, indicate that BA-A may improve depression symptoms in autistic youth without intellectual disability. Furthermore, these promising findings suggest that a randomized controlled trial of BA-A is warranted.
ISSN:1362-3613
1461-7005
DOI:10.1177/13623613241252470